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Background
We recently reported that immunization with cleavage-
defective soluble HIV-1 envelope glycoproteins (Env)
trimers in monkeys, but not in rabbits, results in the elic-
itation of antibodies directed against the co-receptor bind-
ing site of gp120. This finding demonstrates that the high
affinity interaction between Env and primate CD4 results
in an alteration of Env immunogenicity. To further inves-
tigate the impact of Env-CD4 in vivo interactions during
vaccination, we immunized rhesus macaques with wild
type (wt) and CD4 binding defective Env trimers.
Methods
Groups of five adult rhesus macaques were immunized
with wt trimers or CD4 binding defective trimers, with
either retained or abrogated capacity to form the co-recep-
tor binding-site. Plasma and PBMCs were collected 2
weeks post-immunization. Frequency of Env-specific B
and T cells were assessed by ELISpot analysis and flow
cytometry. Serum antibodies were measured by ELISA and
neutralization assays. Four weeks following the last
immunization, control and vaccinated animals were chal-
lenged with SHIVSF162P4.
Results
Antibodies against the co-receptor binding site were elic-
ited in animals immunized with wt trimers, but not in
animals immunized with the CD4-binding defective
mutants. Elimination of the Env-CD4 in vivo interaction
did not affect vaccine-induced Env-specific T cell
responses or levels of total elicited binding antibodies.
However, differences in the quality of the in vitro neutral-
izing antibody response were observed between the three
groups. A comparable decrease in plasma viral loads com-
pared to unvaccinated controls was also measured follow-
ing challenge in all three groups.
Conclusion
These results confirm that the wt Env trimers used here
interact with host CD4 in vivo affecting the quality of the
elicited antibody response. As Env-based vaccines
progress from small animals to primates, the effects of
high affinity CD4 interaction may need to be considered
in regards to immunogen design.
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